002950.SZ
Allmed Medical Products Co., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 9.14
−1.83%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 3.8B | 3.7B | 3.3B | 2.8B | 4.2B |
| Cost of Revenue | 2.7B | 2.6B | 2.4B | 2.0B | 2.8B |
| Gross Profit | 1.1B | 1.1B | 957.4M | 768.6M | 1.4B |
| Operating Expenses | |||||
| R&D Expense | 102.5M | 104.1M | 106.4M | 77.4M | 107.7M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 254.7M | 258.4M | 281.9M | 323.7M | 366.0M |
| Selling & Marketing Expense | 123.9M | 110.0M | 95.9M | 65.7M | 83.8M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 557.0M | 518.3M | 505.0M | 525.9M | 763.2M |
| Cost and Expenses | 3.3B | 3.1B | 2.9B | 2.5B | 3.6B |
| Operating Income (EBIT) | 339.8M | 319.7M | 458.5M | 169.1M | 525.1M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | 329.0M | 309.0M | 454.4M | 169.0M | 484.9M |
| Income Tax Expense | 45.3M | 51.9M | 85.6M | 64.8M | 80.3M |
| Bottom Line | |||||
| Net Income | 271.3M | 248.9M | 368.7M | 110.4M | 406.8M |
| Earnings from Cont. Ops | 283.8M | 257.1M | 368.8M | 104.2M | 404.6M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 271.3M | 248.9M | 368.7M | 110.4M | 406.8M |
| Per Share | |||||
| Basic EPS | CN¥0.43 | CN¥0.40 | CN¥0.59 | CN¥0.17 | CN¥0.64 |
| Diluted EPS | CN¥0.43 | CN¥0.40 | CN¥0.59 | CN¥0.17 | CN¥0.64 |
| Revenue Per Share | CN¥6.19 | CN¥5.93 | CN¥5.32 | CN¥4.24 | CN¥6.65 |
| Shares | |||||
| Basic Shares Outstanding | 615.5M | 618.8M | 625.0M | 649.4M | 633.2M |
| Diluted Shares Outstanding | 615.5M | 618.8M | 625.0M | 649.4M | 633.2M |
| Profitability Metrics | |||||
| EBITDA | — | 559.9M | 686.4M | 395.5M | 718.8M |
| D&A | — | 240.2M | 227.9M | 226.5M | 193.8M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026